Literature DB >> 8843305

Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

P Tajada1, J L Gomez-Graces, J I Alós, D Balas, R Cogollos.   

Abstract

The in vitro activities of 12 beta-lactam agents against 100 thermophilic Campylobacter strains were tested. Beta-Lactamase production was detected in 88% of all strains tested. Clavulanic acid was the best inhibitor by susceptibility testing. The beta-lactams which displayed high levels of in vitro activity against Campylobacter isolates were imipenem, amoxicillin-clavulanic acid, and cefepime and, to a lesser degree, amoxicillin, ampicillin, and cefotaxime.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843305      PMCID: PMC163441     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

Review 1.  Mechanisms of antibiotic resistance in Campylobacter species.

Authors:  D E Taylor; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

Review 2.  Campylobacter jejuni and the expanding spectrum of related infections.

Authors:  B M Allos; M J Blaser
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

3.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.

Authors:  C L Gaudreau; L A Lariviere; J C Lauzer; F F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.

Authors:  J Reina; M J Ros; A Serra
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

6.  Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

7.  Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; L A Larivière
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

8.  Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.

Authors:  J L Gomez-Garces; R Cogollos; J L Alos
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

9.  Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.

Authors:  L A Lariviere; C L Gaudreau; F F Turgeon
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

10.  In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

Authors:  P Van der Auwera; B Scorneaux
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  20 in total

1.  Macrolide resistance in Campylobacter coli of animal origin in Denmark.

Authors:  L B Jensen; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Cloning, Expression, Purification, Regulation, and Subcellular Localization of a Mini-protein from Campylobacter jejuni.

Authors:  Soumeya Aliouane; Jean-Marie Pagès; Jean-Michel Bolla
Journal:  Curr Microbiol       Date:  2016-01-11       Impact factor: 2.188

4.  Whole-Genome Sequencing Analysis Accurately Predicts Antimicrobial Resistance Phenotypes in Campylobacter spp.

Authors:  S Zhao; G H Tyson; Y Chen; C Li; S Mukherjee; S Young; C Lam; J P Folster; J M Whichard; P F McDermott
Journal:  Appl Environ Microbiol       Date:  2015-10-30       Impact factor: 4.792

5.  Presence and characterization of Campylobacter jejuni in organically raised chickens in Quebec.

Authors:  Alexandre Thibodeau; Philippe Fravalo; Sylvette Laurent-Lewandowski; Evelyne Guévremont; Sylvain Quessy; Ann Letellier
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

6.  Isolation and expression of a novel molecular class D beta-lactamase, OXA-61, from Campylobacter jejuni.

Authors:  David A Alfredson; Victoria Korolik
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 7.  A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.

Authors:  A Monselise; D Blickstein; I Ostfeld; R Segal; M Weinberger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-24       Impact factor: 3.267

8.  Development of a selective media for detecting Campylobacter spp. in chicken carcasses using avibactam supplemented mCCDA.

Authors:  Binn Kim; Kun-Ho Seo
Journal:  Food Sci Biotechnol       Date:  2020-04-20       Impact factor: 2.391

9.  Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.

Authors:  Deborah J Griggs; Leanne Peake; Margaret M Johnson; Saba Ghori; A Mott; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

10.  Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.

Authors:  Mirva Lehtopolku; Ulla-Maija Nakari; Pirkko Kotilainen; Pentti Huovinen; Anja Siitonen; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.